PMCTPharmaCountry
    Startseite

Regulatorische Updates

Regulatorische Entwicklungen von FDA, EMA, TGA und weltweit

#ANI Pharmaceuticals ×

UPDATED
Regulatorische Updates
27. Sept. 2026•1 Min. Lesezeit
FDA Approves ANI Pharmaceuticals' Risperidone Oral Solution (ANDA076440)
FDA approved ANDA076440 for ANI Pharmaceuticals' risperidone oral solution (1 mg/mL), a prescription atypical antipsychotic, with recent labeling updates in July 2024.